Covid-19 drug clinical trials in Africa kicks off with Kenya

Influenza vaccine

A high risk patient receives an influenza vaccine.

Photo credit: Johan Nilsson | TT NEWS AGENCY | AFP

The Kenya Medical Research Institute (Kemri) has begun a clinical study to test whether two available drugs in the market can treat Covid-19 patients with mild and moderate symptoms in Africa.

Welcome!

You're all set to enjoy unlimited Prime content.